Trial Profile
Phase II Randomized Study of BAX2398 in Combination With 5-Fluorouracil and Calcium Levofolinate in Japanese Patients With Metastatic Pancreatic Cancer, Which Progressed or Recurred After Prior Gemcitabine-Based Therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Feb 2023
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary) ; Fluorouracil; Levofolinic acid
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Therapeutic Use
- Sponsors Baxalta; Shire
- 28 Jan 2023 Results(n=46) assessing additional safety analysis of Liposomal irinotecan with fluorouracil and leucovorin after gemcitabine-based therapy in Japanese patients with metastatic pancreatic cancer published in the Japanese Journal of Clinical Oncology
- 22 Jan 2022 Results of additional safety of Nal-IRI+5-FU/LV vs 5-FU/LV in metastatic pancreatic cancer, presented at the 2022 Gastrointestinal Cancers Symposium
- 27 Aug 2018 Status changed from active, no longer recruiting to completed.